Tuesday, January 27, 2015 3:06:45 PM
Diabetes Conferences AND start going out to Diabetic user groups and show-and-tell demos of the DRIO mobile reader device.
The very recent diabetic reader device competitor, Dex Com FDA emergent use Approval has not been clarified (as to how it was obtained, example was some form of clinical data testing provided and involved in the FDA Approval Decision). The FDA (kind of) just said, generally to the effect . . . We make no legal decision on the device's (Dex Com) usefulness or medical success at being part of a diabetic care process. <---we just think its new tech that could help in diabetic medical care and want to allow it to be used between the customer/user and the medical health care professional . . . and we want to look over your shoulder and see how it goes.
Personally, unless Dex Com goes into heavy marketing costs . . . I do not foresee more than a few thousand being sold, initially.
Just guessing, I would say DRIO has over 5K of their devices in customer/user hands at this time. Please, if others have better info, please to provide it to the rest of us retail investors walking around with our hands over our eyes. DRIO has not been very fore-coming with device placement figures from within all the countries National Health Care Plans that have approved use of DRIO device reader. This kind of presents a mystery to current and potential retail stock investors, as to what is actually going on herein. If your product is going forward great guns . . . why not toot your own horn a little?
Marketing would be the 'trouble area' for any new product and business venture.
Personally, I have and am taking the bet on DRIO technology. I (and other posters) feel the spotted fox 'will out Watson . . . the game is afoot', within the next few quarters of 2015. If no progress by end of 2015 . . . hmm.
The DRIO product is manufactured in Israel . . . but until just recently DRIO HAD NOT had their government backing. Would not one build their base in-country, as an initial support for going to overseas markets? I guess I funked Marketing 100, oh well.
Be that we present retail investors, believe in DRIO tech potential we sit and await the events of 2015, and are trying to tea leave read the bland DRIO periodic PRs.
New funding scenarios will be more than interesting.
The DRIO Ad budget = online and website, attending professional conferences, and an occasional interview (why do they not go on Dr. Oz type of shows), and it seems they have some retail sales persons that drop into pharma retailers. I should like to see some TV and newspaper ads and calls to senior groups, etc. to attain in store display staffed demos. But DRIO management is so keyed (it seems) to electronic face book type of promotion.
Recent DRIO News
- Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1 • PR Newswire (US) • 06/25/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:02:27 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:01:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 12:30:15 PM
- Empowering Commercial Expansion: DarioHealth Announces Strategic Reorganization and Appoints Inaugural Chief Commercial Officer • PR Newswire (US) • 06/05/2024 12:30:00 PM
- DarioHealth Reports First Quarter 2024 Financial and Operating Results • PR Newswire (US) • 05/15/2024 10:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 10:06:09 AM
- DarioHealth to Report First Quarter 2024 Results on Wednesday, May 15th • PR Newswire (US) • 05/07/2024 12:30:00 PM
- Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes • PR Newswire (US) • 04/25/2024 12:30:00 PM
- Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution • PR Newswire (US) • 04/18/2024 12:30:00 PM
- Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health • PR Newswire (US) • 04/10/2024 12:30:00 PM
- Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health • PR Newswire (US) • 04/02/2024 12:30:00 PM
- DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results • PR Newswire (US) • 03/28/2024 10:30:00 AM
- DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH • PR Newswire (US) • 03/21/2024 12:30:00 PM
- New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications • PR Newswire (US) • 03/12/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:24:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:23:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:21:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:20:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:19:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:16:57 PM
- DARIOHEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE • PR Newswire (US) • 02/28/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:05:57 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM